Authors


Greg Sazima, MD

Latest:

Incorporating Meditation Training Into an Outpatient Psychiatry Practice

Meditation training is a valuable, thoroughly secular tool for psychiatrists to incorporate into our patient practices-and our own personal self-care routines. Here: the basics.


Gregory A. Leskin, PhD

Latest:

Gender Differences in Panic Disorder

According to National Comorbidity Survey data, panic disorder is 2.5 times more prevalent in women than in men. Do physiological changes for women during the perimenstrual and perimenopausal phase play a role in this disorder?


Gregory Briscoe, MD

Latest:

A Literature Review of Videophone Use in Mental Health

In our survey, we found videophones a surprisingly understudied and underutilized tool in spite of the fact that they are easy to use and do not require any technical support.


Gregory Franchini, MD

Latest:

Physician Well Being: Who Cares?

The demands on physicians keep growing-they are not only responsible for assessment, diagnosis, and treatment, they are subject to all manner of related administrative and practice responsibilities. Not surprisingly, physicians are susceptible to burnout.


Gregory K. Farber, PhD

Latest:

New Federal BRAIN Research Discoveries Are Targeted to Improve Clinical Practice

Although the early focus of the NIH component of the BRAIN Initiative is on tool development, the examples listed in this article show that these tools will have relevance to practicing clinicians within the lifetime of the Initiative.


Gregory M. Asnis, MD

Latest:

Treatment of Insomnia in Anxiety Disorders

How often do insomnia and anxiety disorders coexist? And how best to treat patients with comorbid insomnia and anxiety? Answers here..


Gregory M. Pontone, MD

Latest:

Comorbid Movement and Psychiatric Disorders

The goal of this article is to improve recognition of comorbid psychiatric and movement disorders and to help the reader formulate a management strategy using a multidisciplinary approach.


Gregory Pontone, MD

Latest:

Implications of Impulse Control Disorder in Parkinson Disease

The challenges of recognizing behaviors such as hypersexuality, gambling, and excessive buying in Parkinson disease are discussed, as are ways to address them while still managing the underlying condition.


Gregory T. Eells, PhD

Latest:

Working Within a Campus Health Service: A Challenge With Many Rewards

Psychiatrists can provide significant support and insight to patients who are now coming to campus with a wide array of mental health challenges.


Gregory Tau, MD, PhD

Latest:

Effects of Adolescent Marijuana Use on Cognition

In this brief video, an expert summarizes the effects of marijuana use on the teenage brain, as well as new strategies to discuss the consequences of drug use with adolescents.


Greta L. Doctoroff, PhD

Latest:

Infant Psychiatry

Infant, or developmental, psychiatry is a subspecialty of child and adolescent psychiatry that focuses on the promotion of mental health in infants, toddlers, preschoolers, and their families through the consultation, assessment, and treatment of clinical problems.


Gretchen J. Diefenbach, PhD

Latest:

Does TMS Hold Promise for Generalized Anxiety Disorder?

Available data suggest that transcranial magnetic stimulation holds promise as a treatment for GAD. Here: a look at what we know.


Gretchen N. Neigh, PhD

Latest:

Biological Consequences and Transgenerational Impact of Violence and Abuse

Every year, more than 1 million children are exposed to sexual or physical abuse or neglect in the US. The research summarized here clearly demonstrates that exposure to stress before adulthood can result in persistent effects on both mental and physical health.


Group for the Advancement of Psychiatry

Latest:

Can Psychiatry Sustain Connections While Hosting Sustainable Conferences?

Sustainability is more than just cutting carbon emissions. It means creating a system where all of us can thrive—not just survive.


Guido K. W. Frank, MD

Latest:

Novel Research in the Neuropsychiatry of Anorexia Nervosa

Research is now making progress in understanding what happens before and during the illness and how this behavior can be explained.


Guitelle St. Victor, MD

Latest:

Speaking Up: Sexual Harassment in the Medical Setting

Here: a review of the definition of sexual harassment, its prevalence among physicians and medical students, its potential impact on physicians and trainees, and guidance about its management.


Gunnar Morken, MD

Latest:

Seasonal Variation of Violence

The author examines how temperature and length of day can affect mood and behavior, both in a general population and a group of inpatients. In both groups, there were two peaks of violent behavior, one in May-June and one in October-November, which correspond with the equinoxes. Is it possible to track violent behavior in various geographical areas depending upon weather and length of day?


Gunvant K. Thaker, MD

Latest:

Introduction: Schizophrenia Spectrum Disorders

Clinicians have long recognized that many of the psychiatric disorders lack clear boundaries, and that there is a substantial overlap in phenomenology and etiopathophysiology of various disorders.


Guochuan E. Tsai, MD, PhD

Latest:

A New Class of Antipsychotic Drugs

The development of new, more effective antipsychotics with fewer adverse effects (eg, extrapyramidal symptoms, tardive dyskin­esia, metabolic syndrome) is paramount.


Guowei Li

Latest:

What Is the Role of Vitamin D in Depression?

Vitamin D has been hailed as the “sunshine” vitamin with many therapeutic attributes. The authors explore the association between vitamin D deficiency and increased risk of depression.


Gurneet Thiara, MD

Latest:

Psychiatric Care of Patients With Hepatitis C: A Clinical Update

The prevalence of chronic hepatitis C virus infection is among the highest in patients with severe underlying mental illness. Here: clinical information on the interface of HCV infection and psychiatric disorders.


Gustavo Goldstein, MD

Latest:

DSM-5: What It Will Mean to Your Practice

Undoubtedly there will be problems with some of the additions to DSM-5, with some of the combinations, with some of the new nomenclature, and with some of the new criteria sets. But practitioners will find most of DSM-5 to be well considered and well written. It is unfortunate, however, that much of its nomenclature is out of sync with the rest of medicine.


Gustavo H. Vázquez, MD, PhD

Latest:

“Switching” of Mood From Depression to Mania With Antidepressants

Mood switching is not uncommon and it is much more prevalent in depressed juveniles than in depressed adults, and there is a large apparent excess of antidepressant-associated switching over reported spontaneous diagnostic changes to bipolar disorder. Details here.


Guy G. Potter, PhD

Latest:

7 Components of Depression Evaluation

The co-occurrence of depression and cognitive impairment doubles every 5 years after the age of 70. Here we present a list of elements in a comprehensive and extended evaluation of depression in the elderly.


Guy Rordorf, MD

Latest:

Hemicraniectomy for Massive Basal Ganglia Hemorrhage

intracerebral hemorrhage, hemicraniectomy, stroke, neurosurgery, traumatic brain injury


Gwen Wimby, RN, MSA

Latest:

Reducing Risk Associated With Seclusion and Restraint

This article briefly reviews the federal standards regarding S/R and methods of reducing the risk associated with their use. CMS standards that went into effect February 6, 2007, will be emphasized; however, some of these standards vary from JCAHO standards.



H. Blair Simpson, MD, PhD

Latest:

Using the Internet to Increase Access to Evidence-Based Treatment for Obsessive-Compulsive Disorder

Internet-based CBT has shown promise to improve access to therapy for patients with OCD, which is associated with a profoundly diminished quality of life and social isolation.


H. George Nurnberg, MD

Latest:

Options for Management of Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction

Among 25 to 30 million Americans in whom depression is diagnosed annually, 18 to 25 million are treated with antidepressants, of which 90% are SSRI or non-selective serotonin reuptake inhibitor (SRI) antidepressants, the most frequently prescribed medications for all outpatients aged 18 to 65 years.


© 2024 MJH Life Sciences

All rights reserved.